Solvonis Therapeutics says positive data backs SVN-002 IND application

▤ Summary

Solvonis Therapeutics says positive data supports its SVN-002 IND application. The article text is unavailable due to an access denial message, so only the headline can be assessed. The item appears to cover a drug-development milestone rather than a software product or corporate transaction. It is relevant to the pharma sector, but it does not indicate a clear vendor procurement or expansion event.

▦ Linked Companies